{"id":525889,"date":"2021-08-10T08:03:43","date_gmt":"2021-08-10T12:03:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/"},"modified":"2021-08-10T08:03:43","modified_gmt":"2021-08-10T12:03:43","slug":"lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/","title":{"rendered":"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021"},"content":{"rendered":"

<\/p>\n

Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021<\/b><\/p>\n

CARLSBAD, Calif.–(BUSINESS WIRE<\/a>)–Lineage Cell Therapeutics, Inc.<\/a> (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, the Company\u2019s Chief Executive Officer, will be participating in and presenting at the H.C. Wainwright & Co. Inc. Virtual Ophthalmology Conference<\/a>. Mr. Culley\u2019s presentation will be available on-demand starting on August 17th<\/sup>, 2021 at 7am ET \/ 4am PT. Mr. Culley will also participate in an industry panel, Addressing Unmet Medical Needs in Macular Degeneration \u2013 Dry AMD and Stargardt Disease<\/i>, hosted by Yi Chen, Ph.D., CFA, Managing Director, Senior Healthcare Analyst, H.C. Wainwright & Co., Inc., on August 17th<\/sup>, 2021 at 11am ET \/ 8am PT.\n<\/p>\n

\nInterested parties can register to view both the on-demand and live industry panel presentations on the Events and Presentations<\/a> section of Lineage\u2019s website. Additional videos are available on the Media<\/a> page of the Lineage website.\n<\/p>\n

About Lineage Cell Therapeutics, Inc. <\/b><\/p>\n

\nLineage Cell Therapeutics is a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs. Lineage\u2019s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage\u2019s clinical programs are in markets with billion dollar opportunities and include three allogeneic (\u201coff-the-shelf\u201d) product candidates: (i) OpRegen\u00ae<\/sup>, a retinal pigment epithelium transplant therapy in Phase 1\/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1\/2a development for the treatment of subacute spinal cord injuries; and (iii) VAC2, an allogeneic dendritic cell therapy produced from Lineage\u2019s VAC technology platform for immuno-oncology and infectious disease, currently in Phase 1 clinical development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com<\/a> or follow the Company on Twitter @LineageCell<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210810005334\/en\/<\/a><\/span><\/p>\n

Lineage Cell Therapeutics, Inc. IR
\n<\/b>
Ioana C. Hone
\n
(ir@lineagecell.com<\/a>)
\n
(442) 287-8963\n<\/p>\n

Solebury Trout IR
\n<\/b>
Gitanjali Jain Ogawa
\n
(Gogawa@soleburytrout.com<\/a>)
\n
(646) 378-2949\n<\/p>\n

Russo Partners \u2013 Media Relations
\n<\/b>
Nic Johnson or David Schull
\n
Nic.johnson@russopartnersllc.com
\n<\/a>
David.schull@russopartnersllc.com
\n<\/a>
(212) 845-4242\n<\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health Genetics General Health Clinical Trials Pharmaceutical Optical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 CARLSBAD, Calif.–(BUSINESS WIRE)–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, the Company\u2019s Chief Executive Officer, will be participating in and presenting at the H.C. Wainwright & Co. Inc. Virtual Ophthalmology Conference. Mr. Culley\u2019s presentation will be available on-demand starting on August 17th, 2021 at 7am ET \/ 4am PT. Mr. Culley will also participate in an industry panel, Addressing Unmet Medical Needs in Macular Degeneration \u2013 Dry AMD and Stargardt Disease, hosted by Yi Chen, Ph.D., CFA, Managing Director, Senior Healthcare Analyst, H.C. Wainwright & Co., Inc., on … <\/p>\n

Continue reading “Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-525889","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 CARLSBAD, Calif.–(BUSINESS WIRE)–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, the Company\u2019s Chief Executive Officer, will be participating in and presenting at the H.C. Wainwright & Co. Inc. Virtual Ophthalmology Conference. Mr. Culley\u2019s presentation will be available on-demand starting on August 17th, 2021 at 7am ET \/ 4am PT. Mr. Culley will also participate in an industry panel, Addressing Unmet Medical Needs in Macular Degeneration \u2013 Dry AMD and Stargardt Disease, hosted by Yi Chen, Ph.D., CFA, Managing Director, Senior Healthcare Analyst, H.C. Wainwright & Co., Inc., on … Continue reading "Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-10T12:03:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005334r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021\",\"datePublished\":\"2021-08-10T12:03:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/\"},\"wordCount\":464,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210810005334r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/\",\"name\":\"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210810005334r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-08-10T12:03:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210810005334r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210810005334r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/","og_locale":"en_US","og_type":"article","og_title":"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 - Market Newsdesk","og_description":"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 CARLSBAD, Calif.–(BUSINESS WIRE)–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, the Company\u2019s Chief Executive Officer, will be participating in and presenting at the H.C. Wainwright & Co. Inc. Virtual Ophthalmology Conference. Mr. Culley\u2019s presentation will be available on-demand starting on August 17th, 2021 at 7am ET \/ 4am PT. Mr. Culley will also participate in an industry panel, Addressing Unmet Medical Needs in Macular Degeneration \u2013 Dry AMD and Stargardt Disease, hosted by Yi Chen, Ph.D., CFA, Managing Director, Senior Healthcare Analyst, H.C. Wainwright & Co., Inc., on … Continue reading \"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-10T12:03:43+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005334r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021","datePublished":"2021-08-10T12:03:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/"},"wordCount":464,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005334r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/","name":"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005334r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-08-10T12:03:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005334r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210810005334r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lineage-to-present-at-the-h-c-wainwright-ophthalmology-conference-on-august-17-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/525889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=525889"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/525889\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=525889"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=525889"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=525889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}